Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Read More 7 minute read Drinks Industry News Target quietly launches THC-infused beverage pilot in Minnesota: Can big retail handle cannabis next? Target (NYSE: TGT) tests THC-infused hemp beverages in Minnesota, signaling a new era in U.S. retail as big-box stores explore the cannabis drink market. byPallavi MadhirajuOctober 12, 2025